PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026Anticancer Research0 citations

Clinical Outcomes and Prognostic Factors in Pelvic Sarcomas Using Carbon-Ion Radiotherapy

Clinical Outcomes and Prognostic Factors in Patients With Pelvic Sarcomas

View Full Paper

Authors

MKMasanori KawanoYKYuta KubotaIIICHIRO ITONAGA

Discussion

Loading...

Member takes

Overview

Retrospective analysis investigates survival outcomes in pelvic sarcomas, suggesting CIRT improves prognosis.

Key Points

  • This study aims to analyze clinical outcomes and prognostic factors in patients with pelvic sarcomas.
  • Retrospective review of 20 patients treated between 2015 and 2025 at a single institution.
  • Analysis of clinical characteristics, treatment modalities, and outcomes using Kaplan–Meier method.
  • Univariate analyses for associations between clinical variables and survival outcomes.
  • Median overall survival was 33 months and progression-free survival was 32 months.
  • Larger tumor size (≥95 mm) significantly associated with poorer overall survival (OR=21.3, p=0.006).
  • CIRT significantly associated with improved overall survival (OR=0.05, p=0.007).
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kawano et al. (2026) studied this question.

synapsesocial.com/papers/6a192d13fab5b468c4415eadhttps://doi.org/10.21873/anticanres.18215
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Carbon Ion Radiotherapy for Retroperitoneal Sarcoma: A Single-Institution Study2025
  2. 2Surgical management and survival in pelvic osteosarcoma.2026
  3. 3111P Oncologic outcomes of the pelvic bone tumors2024
  4. 4Pelvic Osteosarcoma: Outcomes of Surgically Treated Patients in a Retrospective Single-Center Study2026
  5. 5Prognostic Factors and Outcomes for Post-Radiation Sarcoma—A Systematic Review and Meta-Analysis2026